Nautilus Biotechnology launches eBook on proteomics driving Alzheimer research progress

Nautilus Biotechnology launches eBook on proteomics driving Alzheimer research progress
Nautilus eBook tackles Alzheimer research

Nautilus Biotechnology has published the latest edition of its "Proteomics and neuroscience" eBook, showcasing how its Voyager Platform is being applied to advance research on tau proteoforms in Alzheimer disease and related dementias.

The new volume details innovative insights and experimental techniques that allow scientists to investigate the complexities of neurodegenerative disorders more effectively. The eBook aims to serve as a resource for researchers looking to deepen their understanding of the molecular mechanisms behind these challenging conditions.

Earlier this year, Nautilus Biotechnology presented advances in single molecule proteomics using its Voyager platform at ASMS, with company experts available for discussions on site (link). The company also unveiled research focused on high-accuracy quantification of tau proteoforms at ASMS2026 (link). These efforts align with Nautilus's ongoing work to support proteomics and neuroscience research.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.